Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

Prof

Pharmacy Clinical & Admin Sci

Phone (405) 271-2730

Fax (405) 271-6750

Office COP300

Email Peter-Johnson@ouhsc.edu


Summary

  • President's Associate Presidential Professor
  • Director, PGY2 Pediatric Pharmacy Residency
  • Director, Pediatric Pharmacotherapy Degree Option



Publications & Presentations

    46. Johnson P N. Pediatric critical care. Central South University Pharmacy. 2021 : 560-84

    47. Moore E, Mayes R, Harkin M, Miller J L, Johnson P N. Extended Duration Ketamine Infusions in Critically Ill Children: A Case Report and Review of the Literature. Journal of pediatric intensive care. 2021; 10 : 221-227

    48. Stephens K, Barker P, Bergeron E, Miller J L, Hagemann T M, Lewis T V, Neely S, Johnson P N. Comparison of Clinical Outcomes and Medication Use of Obese Versus Nonobese Children Admitted to the Pediatric Intensive Care Unit. Hospital pharmacy. 2021; 56 : 287-295

    49. Johnson P N. Treprostinil (Remodulin(R)). 2021

    50. Harkin M, Miller J L, Lim S Y, Neely S, Walsh C, Johnson P N. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". The Annals of pharmacotherapy. 2021




Grants

    1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.




Awards and Honors

<< 2 3 4 5 6 7 8 >>
                                                                                            21. University of Oklahoma College of Pharmacy. Outstanding Preceptor. Date: 2015.  

                                                                                            22. Pediatric Pharmacy Advocacy Group. Best Student Investigator Award (Served as student mentor). Date: 2015.  

                                                                                            23. University of Oklahoma College of Medicine, Department of Pediatrics. Best Trainee Research Award (Served as resident mentor). Date: 2015.  

                                                                                            24. Pediatric Pharmacy Advocacy Group. Special Recognition Award. Date: 2015.  

                                                                                            25. ACCP Pediatric Practice and Research Network. Travel Award (Served as student mentor). Date: 2014.  

<< 2 3 4 5 6 7 8 >>



Education

                                                                                            1.  Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.  

                                                                                            2.  Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.  

                                                                                            3.  Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.  

                                                                                            4.  Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.  




Administrative Assignments


no results